Intellia Therapeutics, Inc 10-Q for FY2023 Q2
Intellia Therapeutics, Inc. (NTLA)
10-Q
2023-08-03
For: 2023-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Intellia Therapeutics, Inc filed this 10-Q on August 3, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $13.59M
- down 3.1% from $14.03M a year earlier
- Net loss
- $123.68M
- compared with a net loss of $100.68M a year earlier
- Diluted EPS
- -$1.40
- compared with -$1.33 a year earlier